2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Lung Disease: new trials by email Literature Review of Lung Disease trials Research Report on Lung Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies Nitric oxide, Placebo - Lung Disease | Phase 3 | Completed | Mallinckrodt | 800 | 2005-05-29 | 2021-02-05 |
| Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study Imatinib Mesylate (Gleevec) - Idiopathic Pulmonary Fibrosis, Lung Disease | Phase 2 / Phase 3 | Completed | Daniels, Craig E., M.D. | 120 | 2003-04-01 | 2005-10-05 |
Lung Diseases (2) · Idiopathic Pulmonary Fibrosis (1) · Lung Diseases, Interstitial (1) · Pulmonary Fibrosis (1) · Respiratory Tract Diseases (1)
Fibrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Imatinib Mesylate (1) · Nitric Oxide (1)
Daniels, Craig E., M.D. (1) · Mallinckrodt (1)
Belgium (1) · Finland (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Craig E Daniels, MD (1) · Joseph Lasky, MD (1)
PMID 20007927, PMID 20655106, PMID 23940237, PMID 28046032
2004 (1)